Company Sangui Biotech International, Inc. Other OTC
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 17/12/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+20.16% | 45.51B | |
-8.26% | 38.52B | |
+38.37% | 38.13B | |
+28.11% | 30.74B | |
-13.50% | 26.03B | |
+13.04% | 25.92B | |
+47.13% | 14.13B | |
+35.70% | 12.73B | |
-6.42% | 11.29B |